Categories
I-CARE Early Covid (187)
I-CARE Flu and RSV (36)
I-PREVENT (153)
I-RECOVER Long Covid (111)
I-RECOVER Post-Vaccine (320)
MATH+ (171)
Tags
ACE2 protein (10)
acute respiratory distress syndrome (13)
Alopecia (7)
Anti-inflammatory (8)
Antidepressants (9)
Ascorbic Acid (9)
autoantibodies (10)
autophagy (24)
Calcifediol (6)
Cancer (9)
Corticosteroids (8)
COVID-19 (255)
COVID-19 Vaccines (8)
Curcumin (8)
Cytokines (10)
Depression (10)
Famotidine (14)
flavonoids (5)
Glucocorticoids (6)
Hydroxychloroquine (12)
Hyperbaric Oxygen Therapy (9)
Inflammation (14)
ivermectin (46)
long COVID (21)
Mast Cells (8)
Melatonin (20)
molnupiravir (5)
N-Acetylcysteine (6)
Non-Invasive Brain Stimulation (8)
Omicron (7)
Oxytocin (8)
Pneumonia (8)
quercetin (15)
resveratrol (5)
SARS-CoV-2 (72)
SARS-CoV-2 mRNA Vaccines (7)
Sepsis (15)
spermidine (11)
Spike Protein (10)
Thrombosis (9)
Tinnitus (12)
Valproic Acid (5)
Vitamin C (16)
Vitamin D (9)
Zinc (12)
Conclusions: The results of this case series suggest that high-dose oral famotidine is well tolerated and associated with improved patient-reported outcomes in non-hospitalised patients with COVID-19.
Categories: MATH+
Tags: COVID-19, Famotidine, PROMs, SARS-CoV-2
